Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?

Stoke Therapeutics, Inc. (STOK) shares soared 9.4% in the last trading session to close at $12.60. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 4.5% gain over the past four weeks.Last month, the company achieved alignment with various regulatory agencies across the world related to the design of the phase III EMPEROR study on its pipeline candidate, zorevunersen, for treating Dravet syndrome. Following discussions with the FDA ...